Protocol Ledger

NCT05797792 · Phase III · COMPLETED

CHemical OptImization of Cerebral Embolectomy 2 (CHOICE 2).

Interventional Phase III clinical trial protocol NCT05797792 sponsored by Hospital Clinic of Barcelona in Neurology, Psychiatry, and Pain, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2023-11-18 Enrollment: 440 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT05797792
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)440 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)3 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT05797792
Protocol FieldVerified Registry Value
NCT IdentifierNCT05797792
Consolidated Lead SponsorHospital Clinic of Barcelona
Therapeutic Condition CohortNeurology, Psychiatry, and Pain
Clinical Trial PhasePhase III
Overall Recruitment StatusCOMPLETED
Registered Enrollment440 participants (ACTUAL)
Registered Start Date2023-11-18
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT05797792
Hospital Research SiteLocationSite Profile
Hospital Clinic BarcelonaBarcelona, SpainOpen Hospital Dossier ->
Hospital de La Santa Creu I Sant PauBarcelona, SpainOpen Hospital Dossier ->
Hospital Universitario Central de AsturiasOviedo, SpainOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Neurology, Psychiatry, and Pain Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI